Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024.

CAS  Article  PubMed  Google Scholar 

Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790. https://doi.org/10.1038/s41598-020-71908-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013;4(6):270–81. https://doi.org/10.4239/wjd.v4.i6.270.

Article  PubMed  PubMed Central  Google Scholar 

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. https://doi.org/10.3390/ijms21176275. Papers of particular interest, published recently.

Isordia-Salas I, Galván-Plata ME, Leaños-Miranda A, Aguilar-Sosa E, Anaya-Gómez F, Majluf-Cruz A, et al. Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease. J Diabetes Res. 2014;2014:631902. https://doi.org/10.1155/2014/631902.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cognasse F, Laradi S, Berthelot P, Bourlet T, Marotte H, Mismetti P, et al. Platelet inflammatory response to stress. Front Immunol. 2019;10:1478. https://doi.org/10.3389/fimmu.2019.01478. Papers of particular interest, published recently.

Gross PL, Furie BC, Merrill-Skoloff G, Chou J, Furie B. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukocyte Biol. 2005;78(6):1318–26. https://doi.org/10.1189/jlb.0405193.

CAS  Article  PubMed  Google Scholar 

Darbousset R, Thomas GM, Mezouar S, Frère C, Bonier R, Mackman N, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood. 2012;120(10):2133–2143. https://doi.org/10.1182/blood-2012-06-437772. Papers of particular interest, published recently.

Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost. 1999;81(1):1–7. https://doi.org/10.1055/s-0037-1614407.

CAS  Article  PubMed  Google Scholar 

Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999;93(3):876–85. https://doi.org/10.1182/blood.V93.3.876.

CAS  Article  PubMed  Google Scholar 

Konstantopoulos K, McIntire LV. Perspectives series: cell adhesion in vascular biology. J Clin Invest. 1997;100:S19. https://doi.org/10.1172/JCI119472.

CAS  Article  PubMed  Google Scholar 

Yeo Erik L, Sheppard Jo-Ann I, Feuerstein Irwin A. Role of P-Selectin and Leukocyte Activation in Polymorphonuclear Cell Adhesion to Surface Adherent Activated Platelets Under Physiologic Shear Conditions (An Injury Vessel Wall Model). Blood. 1994;83(9):2498–507 https://doi.org/10.1.1.327.4912.

CAS  Article  Google Scholar 

Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991;17:433–8. https://doi.org/10.1055/s-2007-1002650.

CAS  Article  PubMed  Google Scholar 

Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte cross-talk in diabetes mellitus. Horm Metab Res. 1997;29:631–5. https://doi.org/10.1055/s-2007-979115.

CAS  Article  PubMed  Google Scholar 

Winocour PD, Watala C, Kinlough-Rathbone RL. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects. Thromb Haemost. 1992;67:567–71. https://doi.org/10.1055/s-0038-1648495.

CAS  Article  PubMed  Google Scholar 

Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes. Am J Cardiol. 2003;92:1362–5. https://doi.org/10.1016/j.amjcard.2003.08.033.

CAS  Article  PubMed  Google Scholar 

Assert R, Scherk G, Bumbure A, Pirags V, Schatz H, Pfeiffer AF. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia. 2001;44:188–95. https://doi.org/10.1007/s001250051598.

CAS  Article  PubMed  Google Scholar 

Sugiyama C, Ishizawa M, Kajita K, Morita H, Uno Y, Matsubara K, et al. Platelet aggregation in obese and diabetic subjects: association with leptin level. Platelets. 2007;18:128–34. https://doi.org/10.1080/09537100600819115.

CAS  Article  PubMed  Google Scholar 

Randriamboavonjy V, Fleming I. Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care. 2009;32:528–30. https://doi.org/10.2337/dc08-1942.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Randriamboavonjy V, Pistrosch F, Bölck B, Schwinger RH, Dixit M, Badenhoop K, et al. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mucalpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation. 2008;117:52–60. https://doi.org/10.1161/CIRCULATIONAHA.107.719807.

CAS  Article  PubMed  Google Scholar 

Schaeffer G, Wascher TC, Kostner GM, Graier WF. Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia. 1999;42:167–76. https://doi.org/10.1007/s001250051135.

CAS  Article  PubMed  Google Scholar 

Cangemi R, Pignatelli P, Carnevale R, Nigro C, Proietti M, Angelico F, et al. Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes. 2012;61(6):1626–32. https://doi.org/10.2337/db11-1243.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Carnevale R, Loffredo L, Sanguigni V, Plebani A, Rossi P, Pignata C, et al. Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous disease. J Am Heart Assoc. 2014;3(3):e000920. https://doi.org/10.1161/JAHA.114.000920.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Davì G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322(25):1769–74. https://doi.org/10.1056/NEJM199006213222503.

Article  PubMed  Google Scholar 

Davì G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99(2):224–9. https://doi.org/10.1161/01.cir.99.2.224.

Article  PubMed  Google Scholar 

Zeidana MA, Rageha IM, Kamala HM, Esh AM. Correlation between platelet–monocyte aggregates and prevalence of vascular complications in type II diabetes. Egypt J Haematol. 2013;38:56–62. https://doi.org/10.7123/01.EJH.0000427963.62047.0a.

Article  Google Scholar 

Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24(8):1476–85. https://doi.org/10.2337/diacare.24.8.1476.

CAS  Article  PubMed  Google Scholar 

Nusca A, Tuccinardi D, Pieralice S, Giannone S, Carpenito M, Monte L, et al. Platelet effects of anti-diabetic therapies: New perspectives in the management of patients with diabetes and cardiovascular disease. Front Pharmacol. 2021;12:670155. https://doi.org/10.3389/fphar.2021.670155. Papers of particular interest, published recently.

Ferreira IA, Mocking AI, Feijge MA, Gorter G, van Haeften TW, Heemskerk JW,et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2006;26(2):417–422. https://doi.org/10.1161/01.ATV.0000199519.37089.a0. Papers of particular interest, published recently.

Konieczynska M, Fil K, Bazanek M, Undas A. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Thromb Haemost. 2014;111(4):685–93. https://doi.org/10.1160/TH13-07-0566.

CAS  Article  PubMed  Google Scholar 

Verkleij CJ, Bruijn RE, Meesters EW, Gerdes VE, Meijers JC, Marx PF. The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease. Clin Appl Thromb Hemost. 2011;17(6):E57-63. https://doi.org/10.1177/1076029610384112.

Article  PubMed  Google Scholar 

Hänzelmann S, Wang J, Güney E, Tang Y, Zhang E, Axelsson AS, et al. Thrombin stimulates insulin secretion via protease-activated receptor-3. Islets. 2015;7(4):e1118195. https://doi.org/10.1080/19382014.2015.1118195.

Article  PubMed  Google Scholar 

Nesbitt WS, Westein E, Tovar-Lopez FJ, Tolouei E, Mitchell A, Fu J, et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 2009;15(6):665–73. https://doi.org/10.1038/nm.1955.

CAS  Article  PubMed  Google Scholar 

Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med. 2004;164(20):2273–9. https://doi.org/10.1001/archinte.164.20.2273.

Article  PubMed  Google Scholar 

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93. https://doi.org/10.1056/NEJMoa021778.

Article  PubMed  Google Scholar 

Gresele P, Marzotti S, Guglielmini G, Momi S, Giannini S, Minuz P, et al. Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. Diabetes Care. 2010;33(6):1262–8. https://doi.org/10.2337/dc09-2013.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, et al. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18:147. https://doi.org/10.1186/s12933-019-0952-8. Papers of particular interest, published recently.

Boilard E, Nigrovic PA, Larabee K, Watts GFM, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010;327(5965):580–3. https://doi.org/10.1126/science.1181928.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154(3):485–90. https://doi.org/10.1083/jcb.200105058.

CAS  Article  PubMed  PubMed Central